Ra Pharmaceuticals Inc buy stratec
Start price
20.07.18
/
50%
€9.86
Target price
03.04.20
€51.65
Performance (%)
344.27%
End price
03.04.20
-
Summary
This prediction ended on 03.04.20 with a price of -. The BUY prediction by stratec for Ra Pharmaceuticals Inc saw massive gains of 344.27%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ra Pharmaceuticals Inc | 3.256% | 3.256% | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by stratec for this prediction
In the thread Ra Pharmaceuticals Inc diskutieren
stratec stimmt dem Sentiment von 'Buy' zu
- Ra Pharmaceuticals (NASDAQ:RARX) initiated with Outperform rating and $20 (82% upside) price target at BMO.
Kursziel geändert auf 51,648